Form 4: Blend Labs Officer Sells 25,000 Shares Under 10b5-1 Plan
Insider Transaction Report
Blend Labs' Head of Revenue, Brian Kneafsey, sold 25,000 shares of Class A Common Stock for approximately $2.99 per share under a pre-arranged trading plan.
Summary
- Brian Kneafsey, Head of Revenue at Blend Labs, Inc. (BLND), reported a sale of company stock.
- The transaction involved the disposition of 25,000 shares of Class A Common Stock.
- The shares were sold at a weighted average price of $2.9893 per share, with prices ranging from $2.96 to $3.035.
- This sale was executed on November 17, 2025, pursuant to a Rule 10b5-1 trading plan adopted on March 14, 2025.
- Following this transaction, Kneafsey beneficially owns 662,909 shares of Class A Common Stock directly.
Sentiment
Score: 4
Explanation: The Head of Revenue sold a notable number of shares, which, while executed under a pre-arranged 10b5-1 plan, can be interpreted as a neutral to slightly negative signal regarding management's personal outlook on the stock's immediate future.
Negatives
- An insider, the Head of Revenue, sold a significant number of shares (25,000) at a price of $2.9893 per share.
- While executed under a 10b5-1 plan, insider sales can sometimes be perceived negatively by the market as they might suggest a lack of confidence or a desire to diversify holdings.
Stakeholder Impact
- Shareholders may interpret the insider sale as a neutral to slightly negative signal, potentially influencing short-term sentiment.
Key Dates
| Date | Description |
|---|---|
| 2025-03-14 | Date the Rule 10b5-1 trading plan was adopted by the Reporting Person. |
| 2025-11-17 | Date of the reported transaction (sale of Class A Common Stock). |
| 2025-11-19 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThe sale of shares by a key executive, while part of a pre-arranged 10b5-1 plan, is a data point that investors should consider. It does not inherently signal a strong positive or negative outlook for the company, but it suggests the executive is diversifying or realizing gains. Without further context or other significant news, it primarily supports a 'hold' position for existing investors to observe future developments.
Keywords
Blend Labs, BLND, Insider Sale, Form 4, Brian Kneafsey, 10b5-1 Plan, Equity Transaction, Officer Sale
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.